Virginia Board of Medicine Practitioner Information

Home Icon Home

Search Icon Search

Disclaimer Icon Disclaimers

Links Icon Links

Glossary Icon Glossary

Help Icon Questions


Printer Friendly Version Printer Icon
 

Craig Lee Slingluff Jr., MD

LICENSE # 0101046882
  cls8h@virginia.edu

Issue Date: 7/1/1991
Expiration Date: 6/30/2026
Status: Current Active


General InformationEducationCertifications & Practice AreaInsuranceHonors & AwardsAcademic Appointments & PublicationsProceedings, Actions & ConvictionsPaid Claims
Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.


Academic Appointments
Last Updated 5/3/2024
University Of Virginia School Of Medicine - Charlottesville VA
Rank: Assistant Professor
Years: 1991-1995

University Of Virginia School Of Medicine - Charlottesville VA
Rank: Full Professor
Years: 1991-Present

University Of Virginia School Of Medicine - Charlottesville VA
Rank: Associate Professor
Years: 1995-2000

University Of Virginia School Of Medicine - Charlottesville VA
Rank: Full Professor
Years: 2001-Present

Academic Appointments - Non-US
Last Updated 5/3/2024
None Reported
Publications
(up to ten in the last five years)
Last Updated 5/3/2024
Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in post-resection melanoma patients at high risk of recurrence
Journal for ImmunoTherapy of Cancer
9(10):e003272
Date: 10 2021
doi: 10.1136/jitc-2021-003272.

A pilot trial of vaccination with CEA and Her2 peptides in advanced colorectal cancer
International Journal of Cancer
150(1):164-173
Date: 01 2022
doi: 10.1002/ijc.33793

Melanoma trials that defined surgical management: Overview of trials that established NCCN margin guidelines
Journal of Surgical Oncology
125(1):28-33
Date: 01 2022

The vaccine-site microenvironment: impacts of antigen, adjuvant, and same-site vaccination on antigen presentation and immune signaling
Journal for ImmunTherapy of Cancer
10(3):e003533
Date: 03 2022

An activation to memory trajectory of tumor infiltrating lymphocytes informs metastatic melanoma outcomes
Cancer Cell
40(5):524-544.E5
Date: 05 2022
doi.org/10.1016/j.ccell.2022.04.005

Intratumoral IFN-γ or topical TLR7 agonist promotes infiltration of melanoma metastases by T lymphocytes expanded in the blood after cancer vaccine
Journal for ImmunoTherapy of Cancer
Volume: 11
Date: 02 2023
10.1136/jitc-2022-005952

Barriers to Immune Cell Infiltration in Tumors
Journal for ImmunoTherapy of Cancer
Volume: 11
Date: 04 2023
10.1136/jitc-2022-006401

A Step Toward Personalized Surgical Decision Making: Machine Learning Predicts One Versus Numerous Melanoma Lymph Node Metastases Using RNA-Sequencing
Annals of Surgery
Volume: 278
Date: 09 2023
10.1097/SLA.0000000000005761

Cancer-oocyte SAS1B protein is expressed at the cell surface of multiple solid tumors and targeted with antibody-drug conjugates
Journal for ImmunoTherapy of Cancer
Volume: 12
Date: 03 2024
10.1136/jitc-2023-008430

Multipeptide vaccines for melanoma in the adjuvant setting: long-term survival outcomes and post-hoc analysis of a randomized phase II trial
Nature Communications
Volume: 15
Date: 03 2024
10.1038/s41467-024-46877-6